Mini session 1: IBSA Pharma
Controlled ovarian stimulation protocols in assisted conception: a systematic review and network meta-analysis Pedro Melo, Obstetrics and Gynaecology Doctor, Oxford University Hospitals
Dr Pedro Melo specialises in Obstetrics and Gynaecology in Oxford, having completed his undergraduate medical training in Lisbon and Paris. Pedro is passionate about the role of research in bringing about improvement and innovation into modern clinical practice. His research focuses on evidence synthesis and clinical studies within all areas of assisted conception. He is an editor for the Cochrane Collaboration Gynaecology and Fertility Group and the national clinical coordinator of the NIHR-funded LOCI randomised controlled trial, which investigates ovulation induction drugs in polycystic ovary syndrome. Having just completed a PhD in reproductive medicine at the University of Birmingham, Pedro has recently returned to Oxford to undertake subspecialty training in reproductive medicine.
Mini session 2: Ferring
Follitropin delta: Individualising the dose for your patients Philip Dutton, Clinical Research Fellow in Reproductive Medicine, Liverpool Women’s NHS Foundation Trust, UK
Dr Philip Dutton graduated from The University of Manchester with an MBChB in Medicine and Surgery in 2012. He concurrently achieved distinction for an MRes in Maternal and Fetal Health, in which he examined the role of placental biomarkers in predicting poor pregnancy outcomes in women with reduced fetal movements. Having completed his intermediate training in Obstetrics and Gynaecology, Dr Dutton has been working as a Clinical Research Fellow in Reproductive Medicine at The Hewitt Fertility Centre, Liverpool since 2020. He is also undertaking an MD with The University of Liverpool, examining the ability of vibrational spectroscopic techniques to discriminate adverse early pregnancy outcomes such as ectopic pregnancy and miscarriage. Dr Dutton’s aim is to become a Subspecialty Trainee in Reproductive Medicine and to pursue a career within fertility.
Sponsor’s mini session 3: Fujifilm
Joe Conaghan, Pacific Fertility Center, San Francisco, USA
Joe Conaghan has over three decades of experience in human embryology and is best known for his studies on embryo culture and metabolism. He trained in Embryology and Andrology at the Hammersmith Hospital in London and graduated with a PhD in human embryology from the Royal Postgraduate Medical School at the University of London. He’s a Board-Certified High-complexity Clinical Laboratory Director in the disciplines of Embryology and Andrology. Dr. Conaghan was previously the IVF laboratory director at UCSF for 5 years before moving to Pacific Fertility Center where he has been the director for 20 years. He is a big advocate for eSET in IVF, and therefore for high standards for culturing and vitrifying embryos. Dr. Conaghan is committed to continuing education for IVF lab professionals and dedicates significant time to teaching and mentoring as well as lecturing in Reproductive Technology at San Francisco State University. He lives in Half Moon Bay with his wife and 3 children.
Mini session 4: Kitazato
Experience and benefits of using a heavy paraffin oil for embryo culture Csaba Krisztán, Senior Embryologist, CREATE Fertility
With over 9 years of experience in Embryology and currently working at one of the biggest Fertility groups in Europe, Csaba Krisztán is the Deputy Laboratory Manager at Create Fertility London. Specialized in Embryology and Andrology, he has expertise in training the laboratory crew up to the latest technology and protocols.
Mini session 5: Gedeon Richter
An Introduction to Ganirelix Gedeon Richter Ian Pearce, National Fertility Sales Manager, Gedeon Richter
Mini session 6: Planer
Refining the IVF Lab David Mortimer, President and Co-Owner, Oozoa Biomedical
Sponsor’s mini session 7: Univfy
Maximizing success per patient via AI-supported counselling Dr Mylene Yao, Co-Founder and CEO, Univfy
Dr Yao has more than 20 years of experience in clinical and scientific research in reproductive medicine. Mylene cofounded Univfy, an AI platform focused on personalizing fertility prognostics and expanding fertility treatment success and access. Prior to Univfy, Mylene was faculty at Stanford University where she led NIH-funded research and development of Univfy technology. Mylene received awards and grants for her research on genetic control of pre-implantation embryo development and the role of the uterus in early pregnancy. Mylene obtained her medical degree from University of Toronto, completed Ob/Gyn residency at McGill University and completed Reproductive Endocrinology and Infertility subspecialty training at Brigham and Women’s Hospital. She lives in the San Francisco Bay Area with her family.